How Do You Spell DEFEROXAMINE B?

Pronunciation: [dɪfəɹˈɒksɐmˌiːn bˈiː] (IPA)

Deferoxamine B is a chemical compound used to treat iron overload in the body. Its name may seem daunting to pronounce, but with the help of IPA phonetic transcription, it becomes much more manageable. The word begins with the sound /d/, followed by the long "e" sound /i:/ and the consonants /f/ and /r/. The next syllable is pronounced with the short "o" sound /ɒ/ and the consonants /ks/. The final two syllables contain the sounds /əmeɪn/ and /bi:/, respectively. So, the correct pronunciation of Deferoxamine B is /di:fərɒksəmeɪn bi:/.

DEFEROXAMINE B Meaning and Definition

  1. Deferoxamine B, also known as deferoxamine mesylate, is a pharmaceutical compound classified as an iron-chelating agent. It is a synthetic siderophore that is primarily used for the treatment of iron overload in the body, a condition medically referred to as hemochromatosis. This medication works by binding to excess iron in the body and facilitating its elimination through urine and stool.

    Deferoxamine B is administered either by intravenous infusion or subcutaneous injection. It has a high affinity for iron ions, particularly ferric ions (Fe3+), which allows it to effectively remove excess iron from the bloodstream and tissues. By removing excess iron, deferoxamine B helps prevent iron-induced organ damage and reduces the risk of serious complications associated with iron overload, such as liver cirrhosis, heart failure, and diabetes.

    In addition to its primary use in the treatment of hemochromatosis, deferoxamine B is also employed in the management of acute iron poisoning, particularly from excessive consumption of iron supplements or accidental ingestion of iron-containing products by children. The chelating ability of deferoxamine B helps to capture the excess iron in the gastrointestinal tract, preventing its absorption and reducing its toxic effects.

    Common side effects of deferoxamine B include localized skin reactions at the site of injection, such as redness, pain, and swelling. Rarely, allergic reactions, visual disturbances, and hearing loss may occur. Individuals undergoing deferoxamine B therapy are often monitored closely for changes in kidney function and may need periodic blood tests to assess iron levels in the body.

Common Misspellings for DEFEROXAMINE B

  • seferoxamine b
  • xeferoxamine b
  • ceferoxamine b
  • feferoxamine b
  • referoxamine b
  • eeferoxamine b
  • dwferoxamine b
  • dsferoxamine b
  • ddferoxamine b
  • drferoxamine b
  • d4feroxamine b
  • d3feroxamine b
  • dederoxamine b
  • deceroxamine b
  • deveroxamine b
  • degeroxamine b
  • deteroxamine b
  • dereroxamine b
  • defwroxamine b
  • defsroxamine b

Etymology of DEFEROXAMINE B

The word "Deferoxamine B" has a chemical and pharmaceutical etymology.

"Deferoxamine" is derived from the parent compound "Desferrioxamine", which consists of three parts: "des-" (indicating the removal of something), "ferri" (referring to iron), and "oxamine" (an organic compound containing nitrogen and oxygen). Hence, "desferrioxamine" suggests a substance that removes iron from the body.

The addition of the letter "B" in "Deferoxamine B" signifies a specific variant or derivative of the original compound. The lettering system, such as B, C, D, etc., is usually employed to differentiate related compounds with slight structural modifications or additional properties.

Infographic

Add the infographic to your website: